First Pharmacy UK

Tag: patent challenge

23 Jan

180-Day Exclusivity: How Patent Law Controls Generic Drug Market Entry
The 180-day exclusivity rule under the Hatch-Waxman Act gives the first generic drug maker to challenge a patent a temporary monopoly, delaying competition and keeping prices high. Here’s how it works-and why it’s broken.

By: Wellington Osawe 14 Comments Read More
4 Dec

Paragraph IV Certifications: How Generic Drug Makers Challenge Patents Before Launch
Paragraph IV certifications let generic drug makers challenge brand patents before launch, speeding up affordable drug access. This legal tool under the Hatch-Waxman Act saves billions annually but faces challenges from patent thickets and pay-for-delay deals.

By: Lydia Penhaligon 8 Comments Read More